Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming-Lung Yu

Showing results (331-340 of 527) with videos related to

Pageof 53
Sort By:
The Kaohsiung Journal of Medical Sciences|March 6, 2016
Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in TaiwanMeng-Hsuan Hsieh, Ming-Yen Hsieh, Chung-Feng Huang, et al.
Journal of Hepatology|December 3, 2014
Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infectionChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Cancers|April 23, 2022
Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C PatientsYi-Shan Tsai, Ching-I Huang, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences|June 30, 2019
The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatmentMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|July 10, 2020
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradicationChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Clinical and Molecular Hepatology|July 29, 2024
Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in TaiwanChung-Feng Huang, Chia-Yen Dai, Yi-Hung Lin, et al.
The Kaohsiung Journal of Medical Sciences|April 16, 2024
The efficacy of multi-disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patientsMing-Lun Yeh, Chia-Yen Dai, Chung-Feng Huang, et al.
Hepatology (Baltimore, Md.)|September 11, 2018
A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6Xiao Liu, Xiaoqiong Duan, Jacinta A Holmes, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 31, 2025
Switching to tenofovir alafenamide in virally-suppressed chronic hepatitis B patients with renal/hepatic impairment: Phase 2 study sub-analysis from TaiwanChun-Jen Liu, Young-Suk Lim, Chi-Yi Chen, et al.
The Journal of Infectious Diseases|November 29, 2020
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis BJie Li, Hwai-I Yang, Ming-Lun Yeh, et al.
Pageof 53

Showing results (331-340 of 527) with videos related to

Sort By:
Pageof 53
The Kaohsiung Journal of Medical Sciences|March 6, 2016
Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in TaiwanMeng-Hsuan Hsieh, Ming-Yen Hsieh, Chung-Feng Huang, et al.
Journal of Hepatology|December 3, 2014
Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infectionChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Cancers|April 23, 2022
Circulating Let-7 Family Members as Non-Invasive Biomarkers for Predicting Hepatocellular Carcinoma Risk after Antiviral Treatment among Chronic Hepatitis C PatientsYi-Shan Tsai, Ching-I Huang, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences|June 30, 2019
The prognostic factors between different viral etiologies among advanced hepatocellular carcinoma patients receiving sorafenib treatmentMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
The Kaohsiung Journal of Medical Sciences|July 10, 2020
Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradicationChung-Feng Huang, Chia-Yen Dai, Ming-Lun Yeh, et al.
Clinical and Molecular Hepatology|July 29, 2024
Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in TaiwanChung-Feng Huang, Chia-Yen Dai, Yi-Hung Lin, et al.
The Kaohsiung Journal of Medical Sciences|April 16, 2024
The efficacy of multi-disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patientsMing-Lun Yeh, Chia-Yen Dai, Chung-Feng Huang, et al.
Hepatology (Baltimore, Md.)|September 11, 2018
A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6Xiao Liu, Xiaoqiong Duan, Jacinta A Holmes, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|July 31, 2025
Switching to tenofovir alafenamide in virally-suppressed chronic hepatitis B patients with renal/hepatic impairment: Phase 2 study sub-analysis from TaiwanChun-Jen Liu, Young-Suk Lim, Chi-Yi Chen, et al.
The Journal of Infectious Diseases|November 29, 2020
Association Between Fatty Liver and Cirrhosis, Hepatocellular Carcinoma, and Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis BJie Li, Hwai-I Yang, Ming-Lun Yeh, et al.
Pageof 53